Search
Intensity Therapeutics Inc
INTSAdd to Watchlist
4.100USD
+0.090+2.24%
Close 09-22 16:00（ET）
11.07MMarket Cap
LossP/E TTM
Intensity Therapeutics Inc (INTS) Stock Price Target & Forecast
Analyst Rating
Based on 5 analysts giving stock ratings to Intensity Therapeutics Inc in the past month.
Buy
0 Strong Buy
5 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
17.200USD+318.49%
INTS Analyst Recommendation Trends
In the current month, INTS has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. INTS average Analyst price target in the last month is 17.200.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
5
5
5
5
6
6
5
5
0
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
5
5
6
6
6
6
Financial Forecasting
Based on analysts' estimates, INTS EPS is projected to reach -0.986 in FY2026Q3, following reported EPS of -1.111 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-1.25
-1.08
-0.87
-0.99
-0.75
Actual
-1.31
-0.96
-1.11
--
--
Surprise
-4.76%
+11.47%
-27.33%
--
--
FAQs
What is Intensity Therapeutics Inc's price target?
Analysts forecast that Intensity Therapeutics Inc's price target is USD 3.00, with the highest forecast at USD 5.00 and the lowest forecast at USD 1.50.
How have Intensity Therapeutics IncINTS's recent earnings per share performed?
The market expectation was USD -1.11, while Intensity Therapeutics IncINTS's earnings per share (EPS) for the previous quarter was USD -0.96. EPS for the next quarter is expected at USD -0.99.
What is the analyst rating for Intensity Therapeutics Inc?
Based on the ratings of Intensity Therapeutics Inc's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.